Abstract
Survivin is an inhibitor of apoptosis protein family member that has an essential role in cellular proliferation as a component of the chromosome passenger complex. Survivin is highly expressed in embryos and in proliferating adult tissues, but it is not expressed in most differentiated cells. During tumorigenesis, however, survivin expression is dramatically upregulated. Although many studies have shown that survivin is required for cancer cells, the extent to which survivin contributes to the initiation of tumors is unknown. Here we show that transgenic mice that overexpress survivin in hematopoietic cells are at an increased risk of hematologic tumors. In examining how survivin might contribute to tumorigenesis, we observed that hematopoietic cells engineered to overexpress survivin are less susceptible to apoptosis. We conclude that survivin may promote tumorigenesis by imparting a survival advantage to cells that acquire additional genetic lesions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fleu.2010.198/MediaObjects/41375_2010_Article_BFleu2010198_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fleu.2010.198/MediaObjects/41375_2010_Article_BFleu2010198_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fleu.2010.198/MediaObjects/41375_2010_Article_BFleu2010198_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fleu.2010.198/MediaObjects/41375_2010_Article_BFleu2010198_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fleu.2010.198/MediaObjects/41375_2010_Article_BFleu2010198_Fig5_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fleu.2010.198/MediaObjects/41375_2010_Article_BFleu2010198_Fig6_HTML.jpg)
Similar content being viewed by others
References
Fukuda S, Pelus LM . Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087–1098.
Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000; 96: 1921–1925.
Cong XL, Han ZC . Survivin and leukemia. Int J Hematol 2004; 80: 232–238.
Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ . Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 2004; 22: 1682–1688.
Lopes R, Castro I, Pontes P, Candeias J, Lemoine NR, Sambade C . Expression profile of survivin in acute leukaemias: the importance of differential splicing. Leukemia 2005; 19: 1284–1286.
Fangusaro JR, Caldas H, Jiang Y, Altura RA . Survivin: an inhibitor of apoptosis in pediatric cancer. Pediatr Blood Cancer 2006; 47: 4–13.
Romagnoli M, Trichet V, David C, Clement M, Moreau P, Bataille R et al. Significant impact of survivin on myeloma cell growth. Leukemia 2007; 21: 1070–1078.
Altieri DC . Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8: 61–70.
Okada H, Mak TW . Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4: 592–603.
Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000; 10: 1319–1328.
Ruchaud S, Carmena M, Earnshaw WC . The chromosomal passenger complex: one for all and all for one. Cell 2007; 131: 230–231.
Lu CD, Altieri DC, Tanigawa N . Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998; 58: 1808–1812.
Fukuda S, Pelus LM . Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 2001; 98: 2091–2100.
Xing Z, Conway EM, Kang C, Winoto A . Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004; 199: 69–80.
Okada H, Bakal C, Shahinian A, Elia A, Wakeham A, Suh WK et al. Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med 2004; 199: 399–410.
Altznauer F, Martinelli S, Yousefi S, Thurig C, Schmid I, Conway EM et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004; 199: 1343–1354.
Leung CG, Xu Y, Mularski B, Liu H, Gurbuxani S, Crispino JD . Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J Exp Med 2007; 204: 1603–1611.
Ma AC, Chung MI, Liang R, Leung AY . The role of survivin2 in primitive hematopoiesis during zebrafish development. Leukemia 2009; 23: 712–720.
Fukuda S, Singh P, Moh A, Abe M, Conway EM, Boswell HS et al. Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3. Blood 2009; 114: 394–403.
McCrann DJ, Yezefski T, Nguyen HG, Papadantonakis N, Liu H, Wen Q et al. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice. Blood 2008; 111: 4092–4095.
Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM et al. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 2008; 111: 767–775.
Huang Z, Dore LC, Li Z, Orkin SH, Feng G, Lin S et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol 2009; 29: 5168–5180.
Visvader JE, Fujiwara Y, Orkin SH . Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 1998; 12: 473–479.
Jasinski M, Keller P, Fujiwara Y, Orkin SH, Bessler M . GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells). Blood 2001; 98: 2248–2255.
Hock H, Meade E, Medeiros S, Schindler JW, Valk PJ, Fujiwara Y et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev 2004; 18: 2336–2341.
Altieri DC . Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581–8589.
Fulda S . Inhibitor of apoptosis proteins in hematological malignancies. Leukemia 2009; 23: 467–476.
Guha M, Altieri DC . Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 2009; 8: 2708–2710.
Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest 2001; 108: 991–999.
Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC et al. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res 2003; 63: 567–572.
Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C, Ravid K . Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J 2009; 23: 2741–2748.
Nguyen HG, Ravid K . Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. J Cell Physiol 2005; 208: 12–22.
Acknowledgements
The authors thank Todd Yezefski for initiating these studies and Hui Liu and Jeremy Wen for assistance with animal colony maintenance. This work was supported, in part, by a Grant from the NIH (DK074693). JDC is a Scholar of the Leukemia and Lymphoma Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Small, S., Keerthivasan, G., Huang, Z. et al. Overexpression of survivin initiates hematologic malignancies in vivo. Leukemia 24, 1920–1926 (2010). https://doi.org/10.1038/leu.2010.198
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.198
Keywords
This article is cited by
-
Targeting multifunctional magnetic nanowires for drug delivery in cancer cell death: an emerging paradigm
Environmental Science and Pollution Research (2023)
-
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
Stem Cell Reviews and Reports (2020)
-
Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy
Journal of Experimental & Clinical Cancer Research (2019)
-
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells
BMC Cancer (2017)
-
Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53
Molecular Cancer (2014)